Today's Hours: 8:00am - 10:00pm

Search

Did You Mean:

Search Results

  • Book
    Martin Dreyling, Michael E. Williams, editors.
    Summary: The past decade has witnessed tremendous progress in the diagnostic and therapeutic approaches to malignant lymphoma as well as in understanding of the underlying molecular pathogenesis. Optimal treatment strategies are now based not only on accurate diagnosis but also on thorough evaluation of clinical and molecular risk factors. Even more importantly, molecular targeted approaches have been shown to be effective in the treatment of distinct lymphoma subtypes. Against this background, clinical management of especially the rare lymphomas remains a challenge for the general oncologist. This book provides a comprehensive overview of current treatment strategies in these rare lymphoma subtypes. Experts in the field from around the world describe the histomorphology in a clinically relevant manner, consider the role of risk factors in detail, and discuss the spectrum of therapeutic approaches. Special emphasis is placed on the translation of molecular science into clinical care, and a disease-specific algorithm is proposed for each entity. This book will prove an excellent resource for both experienced and inexperienced practitioners.
    Digital Access Springer 2014
  • Article
    Marusić M.
    Experientia. 1978 Jun 15;34(6):806-7.
    Whether or not parental B lymphocytes cooperate with F1 T lymphocytes depends upon the environment in which parental bone marrow cells differentiate. Only those parental B lymphocytes that have differentiated in the F1 environment are able to cooperate with F1 T lymphocytes.
    Digital Access Access Options